Longview Innovation Corp. 13D/13G Filings for Carisma Therapeutics, Inc. (CARM)

Longview Innovation Corp. 13D and 13G filings for Carisma Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-02
1:06 pm
Sale		 2023-12-31 13G Carisma Therapeutics, Inc.
CARM		 Longview Innovation Corp. 2,713,232
6.700%		 -182,033decrease
(-6.29%)		 Filing
2023-03-16
4:08 pm
Purchase		 2023-03-07 13G Carisma Therapeutics, Inc.
CARM		 Longview Innovation Corp. 2,895,265
7.200%		 2,895,265increase
(New Position)		 Filing